Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_22dac0df31985622b4c1a2ef109cc106 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1617 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1694 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 |
filingDate |
2011-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62bd84f4baba6d8dfd2713eb04a455f2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b921adf1cc7b5c5e785fdd2bcbbb5ac5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2162e05962315d425dd35da4225981fd |
publicationDate |
2011-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2377518-A1 |
titleOfInvention |
Stable aliskiren formulations |
abstract |
An oral pharmaceutical formulation, comprising croscarmellose sodium and internal granules comprising a pharmaceutically acceptable salt or polymorph of aliskiren and stearic acid. |
priorityDate |
2010-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |